Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Current

    • Virtual AcelRx KOL Panel Discussion: The Anticoagulant Market For Dialysis and Update on the Niyad™ Registrational Study

    Join AcelRx Pharmaceuticals (Nasdaq: ACRX) for a KOL panel discussion on the anticoagulant market for dialysis and the Niyad NEPHRO…
    TIME: 11:00 AM EST
    LOCATION: Virtual
    View Details

    Kineta KOL Event to Review New Data from VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors

    Join us for a virtual KOL event with Kineta, featuring immunology expert Michael A. Curran, PhD (MD Anderson Cancer Center Department…
    TIME: 2:00 PM EST
    LOCATION: Virtual
    View Details

    Gamida Cell Thought Leader Fireside Chat

    Join Gamida Cell for a virtual fireside chat with thought leader Gary Schiller, MD, FACP, Professor of Medicine and Director of the Hematological Malignancy/Stem…
    TIME: 4:30 PM EST
    LOCATION: Virtual
    View Details

    BiomX Virtual KOL Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections

    Join BiomX for a virtual KOL event, featuring Dr. Eitan Kerem, M.D. (Hadassah University Medical Center) and Dr. Robert T. “Chip” Schooley,…
    TIME: 12:00 PM EST
    LOCATION: Virtual
    View Details

    Virtual BioAtla Virtual KOL Event – IASLC Data Review: BA3011 in Non-Small Cell Lung Cancer (NSCLC)

    Join us for a virtual KOL Event with BioAtla, featuring Carl M. Gay, MD, PhD (MD Anderson Cancer Center) who will review…
    TIME: 11:00 AM EST
    LOCATION: Virtual
    View Details

    Virtual IDEAYA Biosciences Investor R&D Day: Highlighting IDEAYA’s Synthetic Lethality Pipeline – Scientific Insights and Future Clinical Development Plans

    Join IDEAYA Biosciences for a virtual Investor R&D day featuring GSK and a KOL, showcasing scientific insights and clinical development…
    TIME: 8:00 AM EST
    LOCATION: Virtual
    View Details

    • Immix Biopharma Virtual KOL Event on BCMA-Targeted CAR-T Cell Therapy: NXC-201 Potential in Relapsed/Refractory AL Amyloidosis

    Join Immix Biopharma and key opinion leaders Heather Landau, MD (Director of Amyloidosis Program, Memorial Sloan-Kettering Cancer Center), Vaishali Sanchorawala, MD (Professor,…
    TIME: 4:15 PM EST
    LOCATION: Virtual
    View Details

    PLUS Therapeutics Virtual KOL Event on New Phase 2 ReSPECT-GBM Data in Recurrent Glioblastoma Presented at the Society for NeuroOncology (SNO) Conference

    Join us for a virtual KOL event to discuss new data from the ongoing Phase 2 ReSPECT-GBM trial of rhenium…
    TIME: 10:00 AM EST
    LOCATION: Virtual
    View Details

    Antengene’s 2023 Virtual R&D Day: Clinical Update on Key Cancer Targets (CD24, PD-L1/4-1BB, Claudin 18.2, CD73) Featuring a KOL Session on Tumor Immunotherapy

    Dr. Anthony J. Olszanski, M.D., RPh (Fox Chase Cancer Center) will join Antengene for their 2023 R&D Day. During the event, Antengene’s…
    TIME: 8:30 AM EST
    LOCATION: Virtual
    View Details

    Virtual ALIGOS Therapeutics: Review of ALG-000184 Late Breaker Data (HBV, Phase 1), from The Liver Meeting®, and KOL Perspective on Emerging HBV Therapies

    Join us for a virtual KOL event with ALIGOS Therapeutics, featuring Mark Sulkowski, MD (Johns Hopkins University School of Medicine)…
    TIME: 1:30 PM EST
    LOCATION: Virtual
    View Details

    LifeSci Partners Cocktail Reception at Jefferies London 2023

    Join us for an evening of networking, cocktails, and hors d'oeuvres hosted by LifeSci Partners during the Jefferies London Healthcare…
    TIME: 6:00 PM GMT
    LOCATION: Radio Rooftop, 336-337 Strand London WC2R 1HA United Kingdom
    View Details

    Virtual Arrowhead Pharmaceuticals Virtual Analyst & Investor Event: Review of New Phase 2 Clinical Data on Cardiometabolic Pipeline at AHA 2023

    Join Arrowhead Pharmaceuticals for a virtual analyst and investor event reviewing the new Phase 2 clinical data from the ongoing…
    TIME: 4:30 PM EST
    LOCATION: Virtual
    View Details

    Astria Therapeutics Earnings Webcast

    View the webcast here.
    TIME: 8:30 AM EST
    LOCATION: Virtual
    View Details

    Virtual VYNE Therapeutics Virtual R&D Day: Review of Results from Phase 1b Trial of VYN201 for the Treatment of Vitiligo, Preclinical Data for VYN202 and Development Plans for VYN201 and VYN202

    The event will focus on the therapeutic potential of VYNE's novel and proprietary InhiBETTM platform of its bromodomain and extra-terminal…
    TIME: 1:30 PM EST
    LOCATION: Virtual
    View Details

    Virtual AC Immune KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer’s Disease as a Surrogate of Clinical Efficacy

    Join us virtually via webcast, for a KOL event featuring Prof. Victor Villemagne, MD (University of Pittsburgh), to discuss the heightened…
    TIME: 10:00 AM EST
    LOCATION: Virtual
    View Details

    Virtual Xilio Therapeutics Investor Webcast – Pipeline Progress and SITC Update

    View the webcast here.
    TIME: 8:00 AM EST
    LOCATION: Virtual
    View Details